T1	Outcomes 534 560	Rates of virologic failure
T2	Outcomes 611 637	Treatment discontinuations
T3	Outcomes 742 824	virologic failure and either baseline ABC resistance or regimen sensitivity score.
T4	Outcomes 911 936	reduced virologic failure
T5	Outcomes 1323 1349	treatment discontinuations
T6	Outcomes 1480 1502	adding ABC to EFV+IDV.
T7	Outcomes 1627 1660	effects on nucleoside resistance.
